Exactly. Just takes a small amount of DD knows that the reverse split was always a tool in the plan. Most companies on the OTC don't have a share structure that aligns to a major exchange and also a price structure. Any company uplisting is wise to have an RS pre approved. Heck, you never know when there is a short attack to screw up your plans. Not everyone wants a company to uplist.
Oh lookie...
Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
Post published: September 15, 2022
They had the RS in their tool bag a long time ago
"Additional information concerning the reverse stock split can be found in Silo Pharma’s definitive proxy statement filed with the Securities and Exchange Commission on February 14, 2022."
But wait, there is more...
The stock actually went up
I'm done with this 'daily' topic as I've done my DD and actually look forward to the uplifting after the milestones are hit.